These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 20163435

  • 1. Thickened saliva after effective management of drooling with botulinum toxin A.
    Erasmus CE, Van Hulst K, Van Den Hoogen FJ, Van Limbeek J, Roeleveld N, Veerman EC, Rotteveel JJ, Jongerius PH.
    Dev Med Child Neurol; 2010 Jun; 52(6):e114-8. PubMed ID: 20163435
    [Abstract] [Full Text] [Related]

  • 2. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial.
    Jongerius PH, van den Hoogen FJ, van Limbeek J, Gabreëls FJ, van Hulst K, Rotteveel JJ.
    Pediatrics; 2004 Sep; 114(3):620-7. PubMed ID: 15342830
    [Abstract] [Full Text] [Related]

  • 3. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy.
    Banerjee KJ, Glasson C, O'Flaherty SJ.
    Dev Med Child Neurol; 2006 Nov; 48(11):883-7. PubMed ID: 17044954
    [Abstract] [Full Text] [Related]

  • 4. Botulinum toxin type B for sialorrhoea in children with cerebral palsy: a randomized trial comparing three doses.
    Basciani M, Di Rienzo F, Fontana A, Copetti M, Pellegrini F, Intiso D.
    Dev Med Child Neurol; 2011 Jun; 53(6):559-64. PubMed ID: 21413974
    [Abstract] [Full Text] [Related]

  • 5. Randomized trial of botulinum toxin injections into the salivary glands to reduce drooling in children with neurological disorders.
    Reid SM, Johnstone BR, Westbury C, Rawicki B, Reddihough DS.
    Dev Med Child Neurol; 2008 Feb; 50(2):123-8. PubMed ID: 18201301
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and duration of botulinum toxin treatment for drooling in 131 children.
    Scheffer AR, Erasmus C, van Hulst K, van Limbeek J, Jongerius PH, van den Hoogen FJ.
    Arch Otolaryngol Head Neck Surg; 2010 Sep; 136(9):873-7. PubMed ID: 20855679
    [Abstract] [Full Text] [Related]

  • 7. What could predict effectiveness of Botulinum Toxin to treat drooling: a search for evidence of discriminatory factors on the level of body functions or structures.
    Erasmus CE, van Hulst K, Scheffer AR, van Limbeek J, van den Hoogen FJ, Rotteveel JJ, Jongerius PH.
    Eur J Paediatr Neurol; 2012 Mar; 16(2):126-31. PubMed ID: 21783393
    [Abstract] [Full Text] [Related]

  • 8. Drooling in cerebral palsy: hypersalivation or dysfunctional oral motor control?
    Erasmus CE, Van Hulst K, Rotteveel LJ, Jongerius PH, Van Den Hoogen FJ, Roeleveld N, Rotteveel JJ.
    Dev Med Child Neurol; 2009 Jun; 51(6):454-9. PubMed ID: 19207297
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of sialorrhea in children with cerebral palsy: a double-blind placebo controlled trial.
    Alrefai AH, Aburahma SK, Khader YS.
    Clin Neurol Neurosurg; 2009 Jan; 111(1):79-82. PubMed ID: 18977585
    [Abstract] [Full Text] [Related]

  • 12. Botulinum toxin type A injections can be an effective treatment for pain in children with hip spasms and cerebral palsy.
    Lundy CT, Doherty GM, Fairhurst CB.
    Dev Med Child Neurol; 2009 Sep; 51(9):705-10. PubMed ID: 19459910
    [Abstract] [Full Text] [Related]

  • 13. Botulinum toxin type A on oral health in treating sialorrhea in children with cerebral palsy: a randomized, double-blind, placebo-controlled study.
    Wu KP, Ke JY, Chen CY, Chen CL, Chou MY, Pei YC.
    J Child Neurol; 2011 Jul; 26(7):838-43. PubMed ID: 21551374
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Use of botulinum neurotoxin A in uncontrolled salivation in children with cerebral palsy: a pilot study.
    Tiigimäe-Saar J, Leibur E, Kolk A, Talvik I, Tamme T.
    Int J Oral Maxillofac Surg; 2012 Dec; 41(12):1540-5. PubMed ID: 23068112
    [Abstract] [Full Text] [Related]

  • 17. Botulinum toxin effect on salivary flow rate in children with cerebral palsy.
    Jongerius PH, Rotteveel JJ, van Limbeek J, Gabreëls FJ, van Hulst K, van den Hoogen FJ.
    Neurology; 2004 Oct 26; 63(8):1371-5. PubMed ID: 15505151
    [Abstract] [Full Text] [Related]

  • 18. Long-term effects of botulinum toxin A in children with cerebral palsy.
    Tedroff K, Granath F, Forssberg H, Haglund-Akerlind Y.
    Dev Med Child Neurol; 2009 Feb 26; 51(2):120-7. PubMed ID: 19191845
    [Abstract] [Full Text] [Related]

  • 19. Submandibular duct ligation after botulinum neurotoxin A treatment of drooling in children with cerebral palsy.
    Bekkers S, Pruijn IMJ, Van Hulst K, Delsing CP, Erasmus CE, Scheffer ART, Van Den Hoogen FJA.
    Dev Med Child Neurol; 2020 Jul 26; 62(7):861-867. PubMed ID: 32149393
    [Abstract] [Full Text] [Related]

  • 20. Reduction of salivary flow with botulinum toxin: extended report on 33 patients with drooling, salivary fistulas, and sialadenitis.
    Ellies M, Gottstein U, Rohrbach-Volland S, Arglebe C, Laskawi R.
    Laryngoscope; 2004 Oct 26; 114(10):1856-60. PubMed ID: 15454785
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.